VIVO Cannabis Subsidiary Canna Farms Granted Research License By Health Canada

Canna Farms a wholly-owned subsidiary of VIVO Cannabis Inc. VVCIF VIVO has received a research license from Health Canada allowing it to possess cannabis for the purpose of research. The research license allows Canna Farms to evaluate its medical cannabis products based on taste, smell, feel and visual appeal for research purposes prior to sales of these products.

"We are continually enhancing our product quality for our patients who rely on cannabis as medication," stated Ray Laflamme, Canna Farms' co-founder and VIVO's chief executive officer. "This license allows us to understand the sensory characteristics of our cultivars in various product formats, and offers a competitive advantage for the new products and genetics we bring to market."

The research license also allows Canna Farms to evaluate the products of strategic partners and third-party manufacturers sold on its curated medical e-commerce marketplace.

About VIVO Cannabis

VIVO Cannabis is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company has a collection of brands, including Canna Farms, Beacon Medical, Fireside, and Lumina. Harvest Medicine, VIVO's patient-centric, scalable network of medical cannabis clinics, has serviced over 200,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia.

Photo by Louis Reed on Unsplash

Related News

VIVO Cannabis Stock Up On First Big Returns From Australian Business & 32% YoY 2020 Revenue Increase

Cicatrix Labs Teams Up VIVO Cannabis On Launch Of Assuage Brand Suppositories

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPenny StocksMarketsCanna FarmsRay Laflamme
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.